Biotechnology
The Fungal Frontier: Why Mushrooms Are the Hottest New Asset in the Circular Economy
Discover how biotech start-ups are using fungi to tackle the global waste crisis, creating a groundbreaking new asset class for the circular economy.
The End of an Era: Why Phasing Out Animal Testing is Biotech’s Next Multi-Trillion Dollar Investment Opportunity
A major regulatory shift is ending the era of mandated animal testing, creating a massive financial and competitive advantage for biotech firms.
The Unseen Risk: Why Modern Eugenics is the Next ESG Frontier for Finance
Modern eugenics, cloaked as genetic wellness, poses a systemic risk. For finance and investors, it’s the next frontier of ESG and ethical responsibility.
The Software That Sees: How AI and a New Eye Implant Are Defeating Blindness
A new eye implant powered by AI and intelligent software is restoring vision to the blind, marking a major leap in human-computer interface technology.
The $100 Trillion Silent Pandemic: A Financial Blueprint to Avert Global Economic Collapse
Antimicrobial resistance (AMR) is a $100 trillion threat to the global economy. This article explores a financial blueprint to fix the broken antibiotic market.